IDXX
IDEXX Laboratories, Inc. · Healthcare · Medical - Diagnostics & Research
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -5.6% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q2 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 7 | 0 | 471.56K | $245.77M | n/a | n/a |
| Q2 2026 | 168 | 0 | 55.55M | $29.26B | +7 | −6 |
| Q1 2026 | 170 | +1 | 53.67M | $30.16B | +5 | −5 |
| Q4 2025 | 168 | +2 | 58.18M | $39.32B | +3 | n/a |
| Q3 2025 | 21 | +1 | 29.88M | $19.09B | +1 | −1 |
| Q2 2025 | 18 | 0 | 26.38M | $14.14B | +1 | −1 |
| Q1 2025 | 15 | -2 | 9.43M | $3.96B | n/a | −2 |
| Q4 2024 | 17 | -1 | 9.47M | $3.92B | n/a | −1 |
| Q3 2024 | 17 | +1 | 5.70M | $2.88B | +1 | n/a |
| Q2 2024 | 16 | n/a | 5.12M | $2.49B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (pasivo) | 9.88M | n/a | $5.30B | 0.1% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (pasivo) | 8.37M | n/a | $4.49B | 0.1% | n/c | 1 | SEC ↗ ×22 |
| 3 | State Street Global Advisors ✦ (pasivo) | 3.55M | -2.6% | $1.91B | 0.1% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (pasivo) | 2.46M | +2.3% | $1.32B | 0.1% | ▲ Add | 5 | SEC ↗ ×2 |
| 5 | T. Rowe Price ✦ | 536.10K | -73.0% | $287.53M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 6 | Norges Bank ✦ (pasivo) | 413.83K | +18.9% | $221.95M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 7 | Fidelity (FMR) ✦ | 269.88K | n/a | $144.75M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | AQR Capital Management ✦ | 223.32K | +27.0% | $118.69M | 0.1% | ▲ Add | 5 | SEC ↗ ×6 |
| 9 | Arrowstreet Capital ✦ | 206.14K | +8.0% | $110.56M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 10 | Wellington Management ✦ | 188.17K | -14.3% | $100.92M | 0.0% | ▼ Trim | 5 | SEC ↗ ×4 |
| 11 | Millennium Management ✦ | 78.78K | +99.4% | $42.25M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 12 | Adage Capital Partners ✦ | 59.20K | Nuevo | $31.75M | 0.1% | New | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 43.38K | +3946.8% | $23.27M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 14 | Gotham Asset Management ✦ | 34.66K | +69.5% | $18.59M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 22.66K | -90.5% | $12.15M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Marshall Wace ✦ | 20.00K | -81.9% | $10.73M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 9.70K | -71.8% | $5.20M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | Bridgewater Associates ✦ | 2.62K | -23.6% | $1.41M | 0.0% | ▼ Trim | 5 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Adage Capital Partners | $31.75M | 0.1% |
Posición cerrada
| Fisher Asset Management | $270,227 | era 0.0% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 1,302 tenedores, 70.72M acciones, $38.50B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Director · 2.20K acc. · $1.17M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología